Screening for colorectal cancer

A guidance statement from the american college of physicians

Amir Qaseem, Thomas D. Denberg, Robert H. Hopkins, Linda Humphrey, Joel Levine, Donna E. Sweet, Paul Shekelle

Research output: Contribution to journalArticle

214 Citations (Scopus)

Abstract

Description: Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. Methods: The authors searched the National Guideline Clearinghouse to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. Guidance Statement 1: ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. Guidance Statement 2: ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. Guidance Statement 3: ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. Guidance Statement 4: ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.

Original languageEnglish (US)
Pages (from-to)378-386
Number of pages9
JournalAnnals of Internal Medicine
Volume156
Issue number5
StatePublished - Mar 6 2012
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Guidelines
Physicians
Advisory Committees
Colonoscopy
Radiology
Sigmoidoscopy
Patient Preference
Life Expectancy
Joints
Organizations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Qaseem, A., Denberg, T. D., Hopkins, R. H., Humphrey, L., Levine, J., Sweet, D. E., & Shekelle, P. (2012). Screening for colorectal cancer: A guidance statement from the american college of physicians. Annals of Internal Medicine, 156(5), 378-386.

Screening for colorectal cancer : A guidance statement from the american college of physicians. / Qaseem, Amir; Denberg, Thomas D.; Hopkins, Robert H.; Humphrey, Linda; Levine, Joel; Sweet, Donna E.; Shekelle, Paul.

In: Annals of Internal Medicine, Vol. 156, No. 5, 06.03.2012, p. 378-386.

Research output: Contribution to journalArticle

Qaseem, A, Denberg, TD, Hopkins, RH, Humphrey, L, Levine, J, Sweet, DE & Shekelle, P 2012, 'Screening for colorectal cancer: A guidance statement from the american college of physicians', Annals of Internal Medicine, vol. 156, no. 5, pp. 378-386.
Qaseem A, Denberg TD, Hopkins RH, Humphrey L, Levine J, Sweet DE et al. Screening for colorectal cancer: A guidance statement from the american college of physicians. Annals of Internal Medicine. 2012 Mar 6;156(5):378-386.
Qaseem, Amir ; Denberg, Thomas D. ; Hopkins, Robert H. ; Humphrey, Linda ; Levine, Joel ; Sweet, Donna E. ; Shekelle, Paul. / Screening for colorectal cancer : A guidance statement from the american college of physicians. In: Annals of Internal Medicine. 2012 ; Vol. 156, No. 5. pp. 378-386.
@article{474a8d1662d2459a820a89921fbbdde6,
title = "Screening for colorectal cancer: A guidance statement from the american college of physicians",
abstract = "Description: Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. Methods: The authors searched the National Guideline Clearinghouse to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. Guidance Statement 1: ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. Guidance Statement 2: ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. Guidance Statement 3: ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. Guidance Statement 4: ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.",
author = "Amir Qaseem and Denberg, {Thomas D.} and Hopkins, {Robert H.} and Linda Humphrey and Joel Levine and Sweet, {Donna E.} and Paul Shekelle",
year = "2012",
month = "3",
day = "6",
language = "English (US)",
volume = "156",
pages = "378--386",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Screening for colorectal cancer

T2 - A guidance statement from the american college of physicians

AU - Qaseem, Amir

AU - Denberg, Thomas D.

AU - Hopkins, Robert H.

AU - Humphrey, Linda

AU - Levine, Joel

AU - Sweet, Donna E.

AU - Shekelle, Paul

PY - 2012/3/6

Y1 - 2012/3/6

N2 - Description: Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. Methods: The authors searched the National Guideline Clearinghouse to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. Guidance Statement 1: ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. Guidance Statement 2: ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. Guidance Statement 3: ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. Guidance Statement 4: ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.

AB - Description: Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. Methods: The authors searched the National Guideline Clearinghouse to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. Guidance Statement 1: ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. Guidance Statement 2: ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. Guidance Statement 3: ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. Guidance Statement 4: ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.

UR - http://www.scopus.com/inward/record.url?scp=84857707165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857707165&partnerID=8YFLogxK

M3 - Article

VL - 156

SP - 378

EP - 386

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -